Evaluation of the Regulatory Role of Circular RNA in Tumors and Its Application Value
DOI:
https://doi.org/10.61173/9b28tm90Keywords:
-Circular RNA, tumor treatment, exosomeAbstract
Cancer is a major challenge to public health in China. Its incidence and mortality rates are increasing year by year, and traditional treatment methods are facing limitations such as drug resistance and side effects. This year's research has found that circRNA plays an important role in tumorigenesis, metastasis and drug resistance by regulating mechanisms such as miRNA interaction networks, gene expression and cell cycles. Its stability and specificity make it a novel biomarker and therapeutic target. However, the standardization of circRNA detection techniques is insufficient, and its role in epigenetic regulation and the tumor microenvironment remains unclear. This article systematically analyzes the generation mechanism, functional diversity (such as molecular sponges, protein interactions, and encoded peptides) of circRNAs, as well as their application strategies in cancer treatment (such as exosome detection) and therapy (such as mesenchymal stem cell delivery), revealing the dynamic network by which they regulate tumor drug resistance and cellular metabolism. The research results provide a theoretical basis for the development of non-invasive diagnostic tools and targeted therapies. In the future, it is necessary to combine multi-group masking techniques and engineered delivery systems to break through the bottleneck of detection technology and explore the synergistic mechanism between circRNA and other ncRNAs, so as to promote the clinical transformation of precision cancer medicine.
References
[1] Li M., Hu M., Jiang L., Pei J., and Zhu C., “Trends in cancer incidence and potential associated factors in China,” JAMA Network Open, vol. 7, no. 10, p. e2440381, 2024.
[2] Diao X., Guo C., Jin Y., Li B., Gao X., Du X., Chen Z., Jo M., Zeng Y., Ding C., Liu W., Guo J., Li S., and Qiu H., “Cancer situation in China: an analysis based on the global epidemiological data released in 2024,” Cancer Communications (London, England), vol. 45, no. 2, pp. 178–197, 2025.
[3] Zhang L., Gao H., Li X., Yu F., and Li P., “The important regulatory roles of circRNA encoded proteins or peptides in cancer pathogenesis (Review),” International Journal of Oncology, vol. 64, no. 2, p. 19, 2024.
[4] Zhang Y., Luo J., Yang W., and Ye W. C., “CircRNAs in colorectal cancer: potential biomarkers and therapeutic targets,” Cell Death & Disease, vol. 14, no. 6, p. 353, 2023.
[5] Hwang H. J. and Kim Y. K., “Molecular mechanisms of circular RNA translation,” Experimental & Molecular Medicine, vol. 56, no. 6, pp. 1272–1280, 2024.
[6] Zhu G., Chang X., Kang Y., Zhao X., Tang X., Ma C., and Fu S., “CircRNA: A novel potential strategy to treat thyroid cancer (Review),” International Journal of Molecular Medicine, vol. 48, no. 5, p. 201, 2021.
[7] Hwang H. J. and Kim Y. K., “Molecular mechanisms of circular RNA translation,” Experimental & Molecular Medicine, vol. 56, no. 6, pp. 1272–1280, 2024.
[8] Wang X., Chen T., Li C., Li W., Zhou X., Li Y., Luo D., Zhang N., Chen B., Wang L., Zhao W., Fu S., and Yang Q., “CircRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance in TNBC by destabilizing PKR,” Journal of Hematology & Oncology, vol. 15, no. 1, p. 122, 2022.
[9] Bi W., Huang J., Nie C., Liu B., He G., Han J., Pang R., Ding Z., Xu J., and Zhang J., “CircRNA circRNA_102171 promotes papillary thyroid cancer progression through modulating CTNNBIP1-dependent activation of β-catenin pathway,” Journal of Experimental & Clinical Cancer Research: CR, vol. 37, no. 1, p. 275, 2018.
[10] Li X., Zhang J. L., Lei Y. N., Liu X. Q., Xue W., Zhang Y., Nan F., Gao X., Zhang J., Wei J., Yang L., and Chen L. L., “Linking circular intronic RNA degradation and function in transcription by RNase H1,” Science China Life Sciences, vol. 64, no. 11, pp. 1795–1809, 2021.
[11] Yang S. and Li D., “The role of circRNA in breast cancer drug resistance,” PeerJ, vol. 12, p. e18733, 2024.
[12] Mao M. W., Zhang Z. Y., Wei Y. H., and Wang Z. F., “Circular RNA translation and its application in drug development,” Science China Life Sciences, vol. 54, no. 4, pp. 602–617, 2024.
[13] Fu M., Fang L., Xiang X., et al., “Microarray analysis of circRNAs sequencing profile in exosomes derived from bone marrow mesenchymal stem cells in postmenopausal osteoporosis patients,” Journal of Clinical Laboratory Analysis, vol. 36, no. 1, p. e23916, 2022.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 by the authors.

This work is licensed under a Creative Commons Attribution 4.0 International License.
